24Jan 2024
Identification of Novel Biomarkers in Mesenchymal Stem Cells Reveals Therapeutic Targets for Myelodysplastic Syndrome

Identification of Novel Biomarkers in Mesenchymal Stem Cells Reveals Therapeutic Targets for Myelodysplastic Syndrome

A study analyzed multidimensional data to uncover sequential molecular changes and biomarkers in mesenchymal stem cells (MSC) during Myelodysplastic Syndrome (MDS) transformation. The research identifies HOXB3 and HOXB7 as potential causative genes, offering novel therapeutic and diagnostic targets for MDS. The study showcases enhanced cell proliferation and differentiation and restored hematopoietic support by blocking HOXB3 and HOXB7 in MSCs.

  • #oncology

Like

Save

Share